Anlotinib plus albumin-bound paclitaxel induction-maintenance for sorafenib-refractory radioiodine-refractory differentiated thyroid cancer: A case report and review of literature

Figure 3 Progressive pulmonary metastases on computed tomography following completion of radioiodine therapy. A: The computed tomography (CT) scan obtained 6 months after the third ¹³¹I treatment shows multiple metastatic nodules in both lungs; B: The CT scan obtained 21 months after the third ¹³¹I treatment demonstrates an increase in the size of pulmonary metastases compared with panel A, indicating structural disease progression despite prior radioiodine therapy.